Engineered small extracellular vesicles loaded with miR-654-5p promote ferroptosis by targeting HSPB1 to alleviate sorafenib resistance in hepatocellular carcinoma
Open Access
- 30 September 2023
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-12
Abstract
Sorafenib (sora) is the initial therapy for patients with progressive hepatocellular carcinoma (HCC), but the emergence of drug resistance has seriously impacted its therapeutic efficacy. However, the mechanism of sora resistance remains unclear, and effective strategies to overcome drug resistance are still lacking. By establishing a sora-resistant hepatocellular carcinoma cell line, we found that Heat Shock Protein Family B (small) Member 1 (HSPB1) was markedly upregulated in sora-resistant HCC cells. Further research revealed that the ferroptosis resistance induced by HSPB1 upregulation plays a crucial role in sora resistance. In addition, we confirmed that miR-654-5p enhances sora-induced ferroptosis by binding to HSPB1 and reducing its protein levels. To enhance miRNA stability and delivery efficiency in vivo, we used small extracellular vesicles (sEV) derived from human adipose mesenchymal stem cells as miR-654-5p carriers, creating engineered sEV (m654-sEV). The research demonstrated that m654-sEV effectively delivers miR-654-5p to HCC cells, targeting HSPB1 and enhancing sora-induced ferroptosis. This improves therapeutic effects on sora-resistant HCC cells and xenograft tumors, restoring their sensitivity to sora. In summary, m654-sEV, which targets HSPB1 via miR-654-5p delivery, represents a promising strategy for addressing sora-resistant issue. The combined use of m654-sEV and sora has the potential to significantly enhance therapeutic efficacy for patients with sora-resistant HCC.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2014HM106)
This publication has 43 references indexed in Scilit:
- Exosomes: Therapy delivery tools and biomarkers of diseasesPharmacology & Therapeutics, 2017
- Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosisHepatology, 2016
- MiR-654-5p attenuates breast cancer progression by targeting EPSTI1.2016
- Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinomaJournal of Hematology & Oncology, 2015
- Hsp27 Acts as a Master Molecular Chaperone and Plays an Essential Role in Hepatocellular Carcinoma ProgressionDigestion, 2015
- HSPB1 as a novel regulator of ferroptotic cancer cell deathOncogene, 2015
- Biodistribution and delivery efficiency of unmodified tumor-derived exosomesJournal of Controlled Release, 2015
- Sorafenib for the treatment of hepatocellular carcinomaHepatic Oncology, 2014
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- microRNA FunctionsAnnual Review of Cell and Developmental Biology, 2007